Andrzej Viktor "Andrew" Schally is born in Wilno (now Vilnius) in 1926 to Maria (née Łącka) and Kazimierz Schally. He survives the holocaust while living among the Jewish-Polish Community in Roumania and in 1945 moves to the United Kingdom.
Andrew Schally enters the University of London to study chemistry. He is interested in classical music and practices various sports to stay in shape.
Andrew Schally and Roger Guillemin are awarded the Nobel Prize in Physiology or Medicine in 1977 for their discoveries concerning the peptide hormone production of the brain. They share the prize with Rosalyn Yalow.
Andrew Schally spends a month at the Institute of Biochemistry in Uppsala with J. Porath. He gets expericence in the use of Sephadex and column electrophorensis.
Andrew Schally joins the National Institute of Medical Research in London. He works in a very stimulating environment with R.R. Porter, A.J.P. Martin and W. Cornforth among others and learns about the philosophy of research and systematic apporaches to scientific investigations.
Andrew Schally attends McGill University. He works under D.L. Thomson and M. Saffran in experimental therapeutics. Schally starts research in the hypothalamic field and collaborates with Saffran to demonstrate the presence of the corticotropin releasing factor (CRF) in hypothalamic and neurohypophysial tissue. He obtains his Ph.D. in 1957.
Andrew Schally is appointed Assistant Professor of Physiology at the Baylor University College of Medicine in Houston. He works under R. Guillemin on the isolation of CRF but fails to determine its structure. However he is convinced of the hypothalamic hormones regulating anterior pituitary function.
Andrew Schally is appointed Professor of Medicine at the Tulane University School of Medicine. He serves as the head of the Department of Experimental Medicine between 1980 and 2006.
Andrew Schally enters the Beaconhurst School, Scotland in 1945. He becomes interested in chemistry.
In 1966 Schally's research team isolates thyrotropin-releasing hormone (TRH). Till 1971 they decipher luteinizing-hormone releasing factor (LHRH) and discover growth-releasing hormone (GRH). In addition they study the action of peptide somatostatin. They are able to prove that the pituitary gland is controlled by hormones produced in the hypothalamus.
Andrew Schally is appointed Chief of the Polypeptide Cancer Institute at the Veterans Affairs Medical Center of the University of Miami.
The Veterans Administration Basic Research offers Andrew Schally to set up a new laboratory for Endocrine and Polypeptides studies in 1962. His research team focuses on the study of the central effects of contraceptive steroids and clomiphene. Schally further works on concepts of hormone-dependent tumors and proposes hormonal therapies based on peptide analogs of hypothalamic and other hormones. He frequently collaborates with A. Arimura, A. Gomez-Pan and C. Gual among others.
Andrew Schally marries Ana Maria de Medeiros-Comaru in 1976.